Imunon Inc.

NASDAQ: IMNN · Real-Time Price · USD
6.55
0.15 (2.34%)
At close: Aug 18, 2025, 10:50 AM

Imunon Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 727.16K n/a n/a n/a n/a n/a n/a n/a 125K 125K 125K 125K 125K 125K 125K 125K
Cost of Revenue
164.67K 197.93K 363.58K 189.25K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-164.67K -197.93K 363.58K -189.25K n/a n/a n/a n/a n/a n/a 125K 125K 125K 125K 125K 125K 125K 125K
Operating Income
-2.77M -4.15M -4.15M -4.96M -5.01M -5.01M -5.97M -3.9M -5.47M -5.68M -6.93M -6.17M -5.98M -5.84M -5.49M -5.06M -5.07M -5.38M
Interest Income
27.3K 42.8K 88.96K 115.99K 89.88K 155.39K n/a 264.28K 314.85K 356.15K 262.51K 163.67K 61.95K 14.44K 8.01K 6.29K 1.44K 2.41K
Pretax Income
-2.74M -4.1M -4.06M -4.85M -4.79M -4.93M -6.17M -3.48M -5.56M -5.59M -14.8M -6.15M -6.04M -10.47M -5.6M -5.41M -5.45M -5.69M
Net Income
-2.74M -4.1M -4.06M -4.85M -4.79M -4.93M -4.89M -3.48M -5.56M -5.59M -13.23M -6.15M -6.04M -10.47M -4.22M -5.41M -5.45M -5.69M
Selling & General & Admin
1.38M 1.98M 1.91M 1.67M 2.19M 1.72M 2.41M 1.92M 2.34M 3.06M 4.05M 3.89M 2.88M 2.87M 2.63M 2.72M 2.6M 2.94M
Research & Development
1.23M 2.17M 2.23M 3.29M 2.82M 3.29M 3.55M 1.98M 3.13M 2.62M 3M 2.41M 3.23M 3.1M 2.99M 2.47M 2.59M 2.57M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
2.6M 4.15M 4.15M 4.96M 5.01M 5.01M 5.97M 3.9M 5.47M 5.68M 7.05M 6.3M 6.1M 5.97M 5.62M 5.19M 5.2M 5.51M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a 37.09K 159.99K 150.31K 127.03K 105.02K 4.65M 95.52K 95.52K 221.23K 157.61K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
2.77M 4.15M 4.15M 4.96M 5.01M 5.01M 5.97M 3.9M 5.47M 5.68M 7.05M 6.3M 6.1M 5.97M 5.62M 5.19M 5.2M 5.51M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
1.47M 1.12M 1.11M 1.11M 720.73K 720.65K 720.65K 718.89K 700.47K 634.91K 570.11K 544.24K 535.28K 442.4K 29.49K 442.41K 439.17K 338.86K
Shares Outstanding (Diluted)
1.47M 1.12M 1.11M 1.11M 720.73K 720.65K 720.65K 718.89K 700.47K 634.91K 570.11K 544.24K 535.28K 442.4K 29.49K 442.41K 439.17K 338.86K
EPS (Basic)
-1.87 -3.68 -3.65 -4.38 -6.64 -6.84 -6.78 -4.84 -7.94 -8.81 -23.21 -11.3 -11.29 -23.68 -143.13 -12.23 -12.41 -16.79
EPS (Diluted)
-1.87 -3.68 -3.65 -4.38 -6.64 -6.84 -6.78 -4.84 -7.94 -8.81 -23.21 -11.3 -11.29 -23.68 -143.13 -12.23 -12.41 -16.79
EBITDA
-2.58M -3.95M -3.89M -4.66M -4.6M -4.83M -6.03M -3.28M -5.33M -5.24M -14.43M -5.85M -5.77M -5.65M -5.35M -5.16M -5.03M -5.34M
EBIT
-2.74M -4.15M -4.06M -4.85M -4.79M -5.01M -6.17M -3.48M -5.52M -5.43M -14.65M -6.02M -5.94M -5.83M -5.51M -5.32M -5.23M -5.53M
Depreciation & Amortization
164.67K 197.93K 165.29K 189.25K 185.27K 178.31K 140.56K 198.29K 188.48K 192.68K 218.08K 171.6K 167.97K 173.99K 160.18K 158.94K 193.21K 190.59K